Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Convertible Debt: 2016-2017

Historic Convertible Debt for Fortress Biotech (FBIO) over the last 2 years, with Dec 2017 value amounting to $10.1 million.

  • Fortress Biotech's Convertible Debt was N/A to $18.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $18.1 million, marking a year-over-year change of. This contributed to the annual value of $10.1 million for FY2017, which is 175.14% up from last year.
  • Per Fortress Biotech's latest filing, its Convertible Debt stood at $10.1 million for FY2017, which was up 175.14% from $3.7 million recorded in FY2016.
  • In the past 5 years, Fortress Biotech's Convertible Debt registered a high of $10.1 million during FY2017, and its lowest value of $3.7 million during FY2016.
  • Over the past 2 years, Fortress Biotech's median Convertible Debt value was $6.9 million (recorded in 2016), while the average stood at $6.9 million.
  • Data for Fortress Biotech's Convertible Debt shows a peak YoY surged of 175.14% (in 2017) over the last 5 years.
  • Over the past 2 years, Fortress Biotech's Convertible Debt (Yearly) stood at $3.7 million in 2016, then skyrocketed by 175.14% to $10.1 million in 2017.